» Articles » PMID: 30892634

PLZF Limits Enhancer Activity During Hematopoietic Progenitor Aging

Overview
Specialty Biochemistry
Date 2019 Mar 21
PMID 30892634
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

PLZF (promyelocytic leukemia zinc finger) is a transcription factor acting as a global regulator of hematopoietic commitment. PLZF displays an epigenetic specificity by recruiting chromatin-modifying factors but little is known about its role in remodeling chromatin of cells committed toward a given specific hematopoietic lineage. In murine myeloid progenitors, we decipher a new role for PLZF in restraining active genes and enhancers by targeting acetylated lysine 27 of Histone H3 (H3K27ac). Functional analyses reveal that active enhancers bound by PLZF are involved in biological processes related to metabolism and associated with hematopoietic aging. Comparing the epigenome of young and old myeloid progenitors, we reveal that H3K27ac variation at active enhancers is a hallmark of hematopoietic aging. Taken together, these data suggest that PLZF, associated with active enhancers, appears to restrain their activity as an epigenetic gatekeeper of hematopoietic aging.

Citing Articles

ZBTB16/PLZF regulates juvenile spermatogonial stem cell development through an extensive transcription factor poising network.

Yi C, Kitamura Y, Maezawa S, Namekawa S, Cairns B Nat Struct Mol Biol. 2025; .

PMID: 40033150 DOI: 10.1038/s41594-025-01509-5.


Polyphyllin I exerts anti-hepatocellular carcinoma activity by targeting ZBTB16 to activate the PPARγ/RXRα signaling pathway.

Shan L, Chen Y, An G, Tao X, Qiao C, Chen M Chin Med. 2024; 19(1):113.

PMID: 39182119 PMC: 11344421. DOI: 10.1186/s13020-024-00984-0.


Baf155 controls hematopoietic differentiation and regeneration through chromatin priming.

Wu J, Fan C, Kabir A, Krchma K, Kim M, Kwon Y Cell Rep. 2024; 43(8):114558.

PMID: 39088321 PMC: 11465209. DOI: 10.1016/j.celrep.2024.114558.


Cuproptosis-related gene expression is associated with immune infiltration and CD47/CD24 expression in glioblastoma, and a risk score based on these genes can predict the survival and prognosis of patients.

Li E, Qiao H, Sun J, Ma Q, Lin L, He Y Front Oncol. 2023; 13:1011476.

PMID: 37546426 PMC: 10399623. DOI: 10.3389/fonc.2023.1011476.


A novel Boolean network inference strategy to model early hematopoiesis aging.

Herault L, Poplineau M, Duprez E, Remy E Comput Struct Biotechnol J. 2022; 21:21-33.

PMID: 36514338 PMC: 9719905. DOI: 10.1016/j.csbj.2022.10.040.


References
1.
Suliman B, Xu D, Williams B . The promyelocytic leukemia zinc finger protein: two decades of molecular oncology. Front Oncol. 2012; 2:74. PMC: 3398472. DOI: 10.3389/fonc.2012.00074. View

2.
Moon J, Kim H, Shin M . Rejuvenating Aged Hematopoietic Stem Cells Through Improvement of Mitochondrial Function. Ann Lab Med. 2018; 38(5):395-401. PMC: 5973912. DOI: 10.3343/alm.2018.38.5.395. View

3.
Sidler C, Woycicki R, Li D, Wang B, Kovalchuk I, Kovalchuk O . A role for SUV39H1-mediated H3K9 trimethylation in the control of genome stability and senescence in WI38 human diploid lung fibroblasts. Aging (Albany NY). 2014; 6(7):545-63. PMC: 4153622. DOI: 10.18632/aging.100678. View

4.
McConnell M, Durand L, Langley E, Coste-Sarguet L, Zelent A, Chomienne C . Post transcriptional control of the epigenetic stem cell regulator PLZF by sirtuin and HDAC deacetylases. Epigenetics Chromatin. 2015; 8:38. PMC: 4581162. DOI: 10.1186/s13072-015-0030-8. View

5.
Shen H, Xu W, Guo R, Rong B, Gu L, Wang Z . Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex. Cell. 2016; 165(2):331-42. PMC: 4826479. DOI: 10.1016/j.cell.2016.02.064. View